Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-363,946
Closed -$29.9M 540
2022
Q1
$29.9M Sell
363,946
-14,272
-4% -$1.13M 0.26% 99
2021
Q4
$29M Sell
378,218
-9,928
-3% -$791K 0.24% 111
2021
Q3
$29.2M Sell
388,146
-11,228
-3% -$854K 0.27% 95
2021
Q2
$31.1M Sell
399,374
-216,511
-35% -$16.1M 0.29% 87
2021
Q1
$45.3M Sell
615,885
-104,696
-15% -$7.72M 0.33% 43
2020
Q4
$56.2M Buy
720,581
+30,393
+4% +$2.32M 0.39% 38
2020
Q3
$54.6M Sell
690,188
-14,614
-2% -$1.14M 0.37% 39
2020
Q2
$52M Sell
704,802
-31,003
-4% -$2.33M 0.41% 36
2020
Q1
$54M Buy
735,805
+43,672
+6% +$3.43M 0.5% 27
2019
Q4
$60.1M Sell
692,133
-145,078
-17% -$11.9M 0.41% 32
2019
Q3
$67.2M Sell
837,211
-32,290
-4% -$2.59M 0.41% 43
2019
Q2
$69.6M Buy
869,501
+180,949
+26% +$13.9M 0.47% 27
2019
Q1
$54.6M Sell
688,552
-24,378
-3% -$1.82M 0.4% 39
2018
Q4
$52M Buy
712,930
+141,524
+25% +$9.99M 0.42% 40
2018
Q3
$38.7M Sell
571,406
-1,194
-0.2% -$76.1K 0.3% 79
2018
Q2
$33.2M Sell
572,600
-10,558
-2% -$596K 0.23% 106
2018
Q1
$30.3M Buy
+583,158
New +$31.5M 0.19% 123
2013
Q4
Sell
-141,344
Closed -$6.42M 677
2013
Q3
$6.42M Sell
141,344
-903
-0.6% -$41.2K 0.34% 75
2013
Q2
$6.3M Buy
+142,247
New +$6.35M 0.34% 80

Other funds holding MRK

Mackay Shields LLC's MRK Position: Q2 2022 in Review

Mackay Shields LLC sold out of Merck (MRK) in Q2 2022, closing a stake of 363,946 shares — an estimated $29.9M sold.

Mackay Shields LLC first reported a position in MRK in Q2 2013 and held it in 19 quarters. The position peaked at $69.6M in Q2 2019. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Mackay Shields LLC reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 363,946 Merck shares in Q2 2022, an estimated $29.9M.
  • Mackay Shields LLC first reported a position in Merck in Q2 2013 and held it in 19 quarters.
  • Mackay Shields LLC's Merck position peaked at $69.6M in Q2 2019.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.